ClearPoint Neuro EPS - Earnings per Share 2012-2025 | CLPT
ClearPoint Neuro eps - earnings per share from 2012 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| ClearPoint Neuro Annual EPS | |
|---|---|
| 2024 | $-0.70 |
| 2023 | $-0.90 |
| 2022 | $-0.68 |
| 2021 | $-0.69 |
| 2020 | $-0.43 |
| 2019 | $-0.42 |
| 2018 | $-0.56 |
| 2017 | $-0.93 |
| 2016 | $-2.93 |
| 2015 | $-4.48 |
| 2014 | $-3.20 |
| 2013 | $-4.80 |
| 2012 | $-6.00 |
| 2011 | $-20.80 |
| ClearPoint Neuro Quarterly EPS | |
|---|---|
| 2025-09-30 | $-0.21 |
| 2025-06-30 | $-0.21 |
| 2025-03-31 | $-0.22 |
| 2024-12-31 | $-0.20 |
| 2024-09-30 | $-0.18 |
| 2024-06-30 | $-0.16 |
| 2024-03-31 | $-0.16 |
| 2023-12-31 | $-0.18 |
| 2023-09-30 | $-0.20 |
| 2023-06-30 | $-0.29 |
| 2023-03-31 | $-0.23 |
| 2022-12-31 | $-0.18 |
| 2022-09-30 | $-0.15 |
| 2022-06-30 | $-0.18 |
| 2022-03-31 | $-0.17 |
| 2021-12-31 | $-0.21 |
| 2021-09-30 | $-0.18 |
| 2021-06-30 | $-0.17 |
| 2021-03-31 | $-0.13 |
| 2020-12-31 | $-0.10 |
| 2020-09-30 | $-0.09 |
| 2020-06-30 | $-0.11 |
| 2020-03-31 | $-0.13 |
| 2019-12-31 | $-0.10 |
| 2019-09-30 | $-0.08 |
| 2019-06-30 | $-0.13 |
| 2019-03-31 | $-0.11 |
| 2018-12-31 | $-0.11 |
| 2018-09-30 | $-0.13 |
| 2018-06-30 | $-0.17 |
| 2018-03-31 | $-0.15 |
| 2017-12-31 | $-0.01 |
| 2017-09-30 | $-0.14 |
| 2017-06-30 | $-0.32 |
| 2017-03-31 | $-0.46 |
| 2016-12-31 | $-0.22 |
| 2016-09-30 | $-0.92 |
| 2016-06-30 | $-0.90 |
| 2016-03-31 | $-0.89 |
| 2015-12-31 | $-0.71 |
| 2015-09-30 | $-0.13 |
| 2015-06-30 | $-1.64 |
| 2015-03-31 | $-2.00 |
| 2014-12-31 | $-1.20 |
| 2014-09-30 | $-2.40 |
| 2014-06-30 | $-1.20 |
| 2014-03-31 | $1.60 |
| 2013-12-31 | $-1.20 |
| 2013-09-30 | $-2.00 |
| 2013-06-30 | $-0.80 |
| 2013-03-31 | $-0.80 |
| 2012-12-31 | $2.40 |
| 2012-09-30 | $-2.40 |
| 2012-06-30 | $-0.40 |
| 2012-03-31 | $-5.60 |
| 2011-12-31 | $-4.80 |
| 2011-09-30 | $-5.20 |
| 2011-06-30 | $-5.20 |
| 2011-03-31 | $-5.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.416B | $0.031B |
| ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.458B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $191.785B | 75.04 |
| IDEXX Laboratories (IDXX) | United States | $57.123B | 56.73 |
| Edwards Lifesciences (EW) | United States | $48.948B | 32.82 |
| IQVIA Holdings (IQV) | United States | $40.477B | 22.57 |
| Mettler-Toledo (MTD) | United States | $29.838B | 34.91 |
| DexCom (DXCM) | United States | $27.122B | 37.39 |
| STERIS (STE) | Ireland | $26.367B | 27.22 |
| Waters (WAT) | United States | $23.067B | 30.50 |
| Coloplast (CLPBY) | Denmark | $20.080B | 34.27 |
| Hologic (HOLX) | United States | $16.713B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.207B | 0.00 |
| Penumbra (PEN) | United States | $13.737B | 96.63 |
| Globus Medical (GMED) | United States | $12.510B | 26.26 |
| Masimo (MASI) | United States | $7.630B | 24.45 |
| Glaukos (GKOS) | United States | $6.906B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.194B | 19.68 |
| TransMedics (TMDX) | United States | $4.900B | 58.04 |
| Teleflex (TFX) | United States | $4.552B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.392B | 18.32 |
| Veracyte (VCYT) | United States | $3.286B | 37.45 |
| Integer Holdings (ITGR) | United States | $3.006B | 14.11 |
| Alphatec Holdings (ATEC) | United States | $2.635B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.510B | 23.48 |
| Artivion (AORT) | United States | $2.056B | 94.33 |
| Nihon Kohden (NHNKY) | Japan | $2.038B | 17.79 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| PROCEPT BioRobotics (PRCT) | United States | $1.698B | 0.00 |
| AxoGen (AXGN) | United States | $1.431B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.367B | 0.00 |
| IRadimed (IRMD) | United States | $1.298B | 61.82 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.967B | 5.24 |
| Pulse Biosciences (PLSE) | United States | $0.966B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.814B | 0.00 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.680B | 39.56 |
| Pacific Biosciences Of California (PACB) | United States | $0.667B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.556B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.490B | 13.52 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.431B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| Sight Sciences (SGHT) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.211B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.168B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| CVRx (CVRX) | United States | $0.137B | 0.00 |
| Solana (HSDT) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.55 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Alcon (ALC) | Switzerland | $0.000B | 26.33 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |